Cargando…
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly extended to become a global sanitary and economic emergency. Its etiological agent is the coronavirus SARS-CoV-2. COVID-19 presents a wide spectrum of clinical manifestations, which ranges from an asymptomatic infectio...
Autor principal: | García, Luis F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308593/ https://www.ncbi.nlm.nih.gov/pubmed/32612615 http://dx.doi.org/10.3389/fimmu.2020.01441 |
Ejemplares similares
-
Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19
por: Zhang, Qiong, et al.
Publicado: (2021) -
Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19
por: Ai, Yanling, et al.
Publicado: (2023) -
The Role of Semaphorins and Their Receptors in Innate Immune Responses and Clinical Diseases of Acute Inflammation
por: Kanth, Shreya M., et al.
Publicado: (2021) -
The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020) -
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
por: Colafrancesco, Serena, et al.
Publicado: (2020)